English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Glycohemoglobin (GHB) is routinely used both as an index of mean glycemia and as a measure of risk for the development and progression of diabetes complications (1)(2). Because the prevalence of diabetes is higher for non-Hispanic blacks than in non-Hispanic whites (3) and at least 10% of black Americans have either hemoglobin S (HbS) or HbC trait (4), it is probable that at least 150 000 Americans with diabetes have HbS or HbC trait.Previous studies have shown that some GHB methods yield inaccurate results with samples heterozygous for HbS or HbC (5)(6)(7)(8)(9). Many of these interference studies have used boronate affinity chromatography as a reference method based on the assumption that this method should not be influenced by the presence of Hb variants (10). Because measurement of GHB by boronate affinity chromatography is based on the structure of the glycated component (cis-diol component of GHB), rather than differences in charge, it has been assumed that glycated HbS and/or HbC are included in the glycated fraction and that GHB results obtained …

clinical chemistry

Validation by a Mass Spectrometric Reference Method of Use of Boronate Affinity Chromatography to Measure Glycohemoglobin in the Presence of Hemoglobin S and C Traits